Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Down or out in blood and lymph?

New studies indicate that relatively few infected cells can sustain an HIV infection. Combining this knowledge with powerful multi-drug therapy, it may now be possible to eradicate HIV in a patient within two to three years. Time will tell.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. 1. Chun, T.-W. etal. Nature 387, 183-188 (1997). 2. Perelson, A. S. etal. Nature387, 188-191 (1997). 3. Ho, D. D. etal. Nature373, 123-126 (1995). 4. Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. Science 271, 1582-1586 (1996). 5. Wei,X. etal. Nature373, 117-122 (1995). 6. Dimitrov, D. S. etal. J. Virol. 67, 2182-2190 (1993). 7. Freitas, A. A. & Rocha, B. B. Immunol Today 14, 25-29 (1993). 8. McLean, A. R. & Michie, C. A. Proc. NatlAcad. Set. USA 92,3707-3711 (1995). 9. Wain-Hobson, S. Nature 366, 22 (1993).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wain-Hobson, S. Down or out in blood and lymph?. Nature 387, 123–124 (1997). https://doi.org/10.1038/387123a0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/387123a0

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing